STOCK TITAN

[Form 4] CAMPBELL'S Co Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Form 4: Director Fabiola R. Arredondo reported a transaction in Campbells Co (CPB). On 09/25/2025 she acquired 1,325 shares of Common Stock at a reported price of $0. Following the transaction she beneficially owned 28,331 shares. The filing indicates the reporter is a Director and was signed by Marci K. Donnelly, Attorney-in-Fact, on 09/26/2025.

Form 4: La Consigliera Fabiola R. Arredondo ha riportato una transazione in Campbell's Co (CPB). Il 25/09/2025 ha acquistato 1.325 azioni ordinarie a un prezzo riportato di $0. Dopo la transazione deteneva 28.331 azioni in modo beneficiario. La documentazione indica che la relazione è di una Consigliera e è stata firmata da Marci K. Donnelly, procuratore, il 26/09/2025.

Form 4: La Directora Fabiola R. Arredondo informó una transacción en Campbell's Co (CPB). El 25/09/2025 adquirió 1.325 acciones de acciones comunes a un precio informado de $0. Después de la operación, poseía 28.331 acciones de forma beneficiosa. El archivo indica que la informante es una Directora y fue firmada por Marci K. Donnelly, mandatario, el 26/09/2025.

Form 4: 이사 Fabiola R. Arredondo은 Campbell's Co (CPB)에서의 거래를 보고했습니다. 2025년 9월 25일 그녀는 공통주 1,325주를 취득했으며 보고된 가격은 $0입니다. 거래 후 그녀는 28,331주를 소유했습니다. 제출서는 보고자가 이사임을 나타내며 2025년 9월 26일 Marci K. Donnelly, 대리인(Attorney-in-Fact)이 서명했습니다.

Form 4 : La Directrice Fabiola R. Arredondo a signalé une transaction chez Campbell's Co (CPB). Le 25/09/2025, elle a acquis 1 325 actions ordinaires à un prix rapporté de 0 $. Suite à la transaction, elle détenait 28 331 actions de manière bénéficiaire. Le dossier indique que la déclarant est une Directrice et il a été signé par Marci K. Donnelly, mandataire, le 26/09/2025.

Formular 4: Die Direktorin Fabiola R. Arredondo meldete eine Transaktion bei Campbell's Co (CPB). Am 25.09.2025 hat sie 1.325 Stammaktien zu einem gemeldeten Preis von $0 erworben. Nach der Transaktion besaß sie 28.331 Aktien wirtschaftlich. Die Einreichung gibt an, dass die Melderin eine Direktorin ist und von Marci K. Donnelly, Bevollmächtigte, am 26.09.2025 unterschrieben wurde.

Form 4: أبلغت المديرة فابيولا ر. أريهنددو عن عملية في Campbell's Co (CPB). في 25/09/2025 اشترت 1,325 سهماً من الأسهم العادية بسعر مُبلغ عنه قدره $0. بعد الصفقة أصبحت تملك 28,331 سهماً بشكل مستفيد. تشير الملفات إلى أن المبلِّغة هي مديرة وتم توقيعها من قبل مارسي ك. دونيلي، وكيل/وكيل حقيقي، في 26/09/2025.

Form 4: 董事 Fabiola R. Arredondo 已就 Campbell's Co(CPB)的一笔交易进行了报告。2025年9月25日,她< b>购买了1,325股普通股,披露价格为$0。交易后她实际拥有28,331股。备案显示报告人是董事,并由代理人 Marci K. Donnelly 于 2025年9月26日签署。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A director reported a non-derivative acquisition of 1,325 shares, raising her total to 28,331 shares; transaction price reported as $0.

The filing documents a small, outright acquisition by a director of common stock rather than an option exercise or derivative. The reported price of $0 is unusual in equity purchase reporting and may reflect a grant, stock distribution, or clerical reporting convention; the Form 4 itself does not explain the price. The transaction size (1,325 shares) is modest relative to large-cap market caps and does not by itself imply a material change to ownership or control.

TL;DR: Director-level insider disclosed acquisition; disclosure meets Section 16 reporting but lacks narrative on consideration or source.

From a governance perspective, timely disclosure of the directors transaction is appropriate and consistent with Section 16 obligations. The filing identifies the reporter as a director and provides post-transaction beneficial ownership. The absence of an explanation for the $0 price in the remarks section limits clarity about whether this was a grant, dividend reinvestment, or reporting artifact. The document contains the required signature by an attorney-in-fact.

Form 4: La Consigliera Fabiola R. Arredondo ha riportato una transazione in Campbell's Co (CPB). Il 25/09/2025 ha acquistato 1.325 azioni ordinarie a un prezzo riportato di $0. Dopo la transazione deteneva 28.331 azioni in modo beneficiario. La documentazione indica che la relazione è di una Consigliera e è stata firmata da Marci K. Donnelly, procuratore, il 26/09/2025.

Form 4: La Directora Fabiola R. Arredondo informó una transacción en Campbell's Co (CPB). El 25/09/2025 adquirió 1.325 acciones de acciones comunes a un precio informado de $0. Después de la operación, poseía 28.331 acciones de forma beneficiosa. El archivo indica que la informante es una Directora y fue firmada por Marci K. Donnelly, mandatario, el 26/09/2025.

Form 4: 이사 Fabiola R. Arredondo은 Campbell's Co (CPB)에서의 거래를 보고했습니다. 2025년 9월 25일 그녀는 공통주 1,325주를 취득했으며 보고된 가격은 $0입니다. 거래 후 그녀는 28,331주를 소유했습니다. 제출서는 보고자가 이사임을 나타내며 2025년 9월 26일 Marci K. Donnelly, 대리인(Attorney-in-Fact)이 서명했습니다.

Form 4 : La Directrice Fabiola R. Arredondo a signalé une transaction chez Campbell's Co (CPB). Le 25/09/2025, elle a acquis 1 325 actions ordinaires à un prix rapporté de 0 $. Suite à la transaction, elle détenait 28 331 actions de manière bénéficiaire. Le dossier indique que la déclarant est une Directrice et il a été signé par Marci K. Donnelly, mandataire, le 26/09/2025.

Formular 4: Die Direktorin Fabiola R. Arredondo meldete eine Transaktion bei Campbell's Co (CPB). Am 25.09.2025 hat sie 1.325 Stammaktien zu einem gemeldeten Preis von $0 erworben. Nach der Transaktion besaß sie 28.331 Aktien wirtschaftlich. Die Einreichung gibt an, dass die Melderin eine Direktorin ist und von Marci K. Donnelly, Bevollmächtigte, am 26.09.2025 unterschrieben wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ARREDONDO FABIOLA R

(Last) (First) (Middle)
ONE CAMPBELL PLACE

(Street)
CAMDEN NJ 08103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CAMPBELL'S Co [ CPB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/25/2025 A 1,325 A $0 28,331 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Marci K. Donnelly, Attorney-in-Fact 09/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
The Campbell's Company

NASDAQ:CPB

CPB Rankings

CPB Latest News

CPB Latest SEC Filings

CPB Stock Data

9.20B
193.18M
35.14%
64.51%
8.78%
Packaged Foods
Food and Kindred Products
Link
United States
CAMDEN